 |
Colchicine |
|---|---|
| Trade Name | |
| Orphan Indication | For arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1985-12-09 00:00:00 |
| Sponsor | Pharmacontrol Corporation;661 Palisade Ave., P.O. Box 931;Englewood Cliffs, New Jersey, 07632 |
